Mario Boccadoro Selected Research

Mario Boccadoro Research Topics

Disease

150	Multiple Myeloma 10/2022 - 06/2002
34	Neoplasms (Cancer) 06/2021 - 04/2003
14	Neutropenia 12/2021 - 04/2009
12	Infections 12/2021 - 08/2007
12	Residual Neoplasm 12/2020 - 04/2003
9	Disease Progression 01/2022 - 06/2005
9	Hematologic Neoplasms (Hematological Malignancy) 03/2019 - 10/2002
6	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2021 - 01/2006
6	Lymphoma (Lymphomas) 01/2018 - 04/2003
6	Anemia 01/2018 - 06/2004
5	Chemotherapy-Induced Febrile Neutropenia 06/2019 - 01/2016
5	Renal Insufficiency (Renal Failure) 10/2018 - 06/2004
5	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2016 - 06/2004
4	Thrombocytopenia (Thrombopenia) 01/2021 - 01/2006
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 08/2014 - 05/2004
4	Peripheral Nervous System Diseases (PNS Diseases) 06/2014 - 01/2006
4	Thromboembolism 03/2011 - 10/2005
3	Immunoglobulin Light-chain Amyloidosis 07/2022 - 01/2018
3	Febrile Neutropenia 06/2019 - 02/2016
3	Monoclonal Gammopathy of Undetermined Significance 01/2018 - 09/2007
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 07/2008 - 04/2003
2	Pneumonia (Pneumonitis) 12/2021 - 01/2021
2	Frailty 10/2020 - 01/2020
2	Leukemia 01/2020 - 10/2002
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 03/2018 - 01/2004
2	Primary Myelofibrosis (Myelosclerosis) 01/2018 - 01/2016
2	Plasma Cell Leukemia 01/2016 - 06/2013
2	Inflammation (Inflammations) 01/2016 - 06/2005
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2014 - 05/2004
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 11/2013 - 12/2006
2	Osteonecrosis (Kienbock's Disease) 01/2013 - 11/2008

Drug/Important Bio-Agent (IBA)

42	Bortezomib (Velcade)FDA Link 12/2021 - 06/2005
36	Lenalidomide (CC 5013)FDA Link 10/2022 - 07/2007
35	Dexamethasone (Maxidex)FDA LinkGeneric 10/2022 - 01/2004
35	Thalidomide (Thalomid)FDA Link 12/2021 - 01/2004
34	Melphalan (Alkeran)FDA LinkGeneric 03/2022 - 08/2002
30	Prednisone (Sone)FDA LinkGeneric 12/2020 - 10/2005
14	Proteasome InhibitorsIBA 01/2022 - 06/2005
10	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2021 - 02/2009
10	Monoclonal AntibodiesIBA 09/2021 - 04/2008
9	daratumumabIBA 01/2022 - 01/2019
8	carfilzomibIBA 03/2022 - 07/2014
8	Pharmaceutical PreparationsIBA 06/2020 - 07/2006
6	Immunomodulating AgentsIBA 09/2021 - 07/2008
6	Filgrastim (Neupogen)FDA Link 06/2019 - 01/2016
6	Biosimilar PharmaceuticalsIBA 06/2019 - 01/2016
5	AntigensIBA 11/2020 - 06/2012
5	Alkylating AgentsIBA 01/2020 - 07/2007
5	SteroidsIBA 01/2020 - 10/2005
4	pomalidomideIBA 01/2022 - 10/2013
4	ixazomibIBA 12/2021 - 01/2018
4	OligonucleotidesIBA 01/2019 - 02/2009
4	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 11/2017 - 10/2012
4	Erythropoietin FDA Link 01/2016 - 06/2004
4	Rituximab (Mabthera)FDA Link 11/2013 - 12/2006
3	elotuzumabIBA 10/2022 - 01/2021
3	Chimeric Antigen ReceptorsIBA 01/2021 - 01/2019
3	Immunoglobulin M (IgM)IBA 01/2021 - 09/2007
3	Proteins (Proteins, Gene)FDA Link 06/2020 - 10/2014
3	CytokinesIBA 01/2019 - 06/2005
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2015 - 02/2006
3	liposomal doxorubicin (Doxil)FDA Link 08/2013 - 04/2007
3	Cholecalciferol (Vitamin D3)FDA Link 07/2012 - 05/2004
3	Immunoglobulins (Immunoglobulin)IBA 06/2012 - 01/2005
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2012 - 10/2007
3	Enoxaparin (Lovenox)FDA LinkGeneric 01/2012 - 03/2006
3	Proteasome Endopeptidase Complex (Proteasome)IBA 03/2009 - 07/2006
3	AnticoagulantsIBA 04/2008 - 10/2005
3	Hemoglobins (Hemoglobin)IBA 09/2007 - 06/2005
2	VaccinesIBA 12/2021 - 08/2007
2	Hypoxia-Inducible Factor 1IBA 06/2021 - 01/2020
2	fludarabineIBA 01/2020 - 01/2006
2	Phosphotransferases (Kinase)IBA 01/2020 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 12/2010
2	ruxolitinibIBA 01/2018 - 01/2016
2	LigandsIBA 01/2018 - 10/2012
2	Immunoglobulin G (IgG)IBA 01/2018 - 09/2007
2	MicroRNAs (MicroRNA)IBA 06/2013 - 09/2008
2	Diphosphonates (Bisphosphonates)IBA 01/2013 - 11/2008
2	Mevalonic Acid (Mevalonate)IBA 10/2012 - 12/2010
2	Isotretinoin (Accutane)FDA LinkGeneric 07/2012 - 02/2009
2	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2012 - 04/2008
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2012 - 03/2011
2	Zoledronic Acid (Zometa)FDA Link 12/2010 - 10/2008
2	defibrotideIBA 07/2010 - 02/2009

Therapy/Procedure

64	Therapeutics 01/2022 - 08/2002
29	Drug Therapy (Chemotherapy) 07/2022 - 08/2002
24	Stem Cell Transplantation 03/2022 - 10/2002
10	Autologous Transplantation 12/2021 - 06/2002
10	Homologous Transplantation 02/2016 - 06/2004
9	Transplantation 12/2021 - 10/2002
6	Salvage Therapy 03/2022 - 08/2007
6	Immunotherapy 11/2020 - 06/2005
3	Hematopoietic Stem Cell Transplantation 01/2020 - 07/2012
3	Drug Tapering 06/2014 - 04/2008
3	Cell Transplantation 06/2013 - 06/2006
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2019 - 08/2007
2	Radiotherapy 11/2018 - 06/2005
2	Antibiotic Prophylaxis 01/2017 - 11/2008
2	Duration of Therapy 10/2015 - 03/2014